Ka Yin Lui Selected Research

Liver Diseases (Liver Disease)

1/2022

Population pharmacokinetic model-guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ka Yin Lui Research Topics

Disease

2	Critical Illness (Critically Ill) 01/2023 - 01/2022
2	Sepsis (Septicemia) 11/2021 - 01/2019
1	Pressure Ulcer (Bedsore) 06/2023
1	Candidiasis (Moniliasis) 01/2023
1	Infections 01/2022
1	Invasive Fungal Infections 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2016

Drug/Important Bio-Agent (IBA)

2	Voriconazole (Vfend)FDA LinkGeneric 01/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2016
1	Antifungal AgentsIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 11/2021
1	Dichlorodiphenyldichloroethane (DDD)IBA 11/2021

Therapy/Procedure

2	Critical Care (Surgical Intensive Care) 06/2023 - 01/2019
2	Therapeutics 01/2023 - 01/2022